To check fixation accuracy of visual field analyzer and assure the lenses does not cause artifact.
- Conditions
- Health Condition 1: H409- Unspecified glaucoma
- Registration Number
- CTRI/2019/05/019216
- Lead Sponsor
- Dr Agarwals eye hospitals
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
In the control group;
The subjects with the age of 17 to 80 years with visual acuity 6/9 or better ; with distance spherical correction between -6D to +2D or cylindrical correction less than 3D; with clear media; and IOP less than 22 mmHg ;with normal fundus; with no family history of glaucoma ; with no systemic diseases were included in the study.
The glaucoma group;
In glaucoma, the IOP should be controlled and early glaucomatous subjects were only included in the study.
Reports with False positive and False negative greater than 33% were excluded from the study.
Patients who had undergone ocular surgeries, patients with ocular disease other than glaucoma, amblyopia and other neurological disorders were excluded from the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The abitlity of the new device Elisar Visual field analyzer to correctly identify localize the blindspotTimepoint: 4 weeks
- Secondary Outcome Measures
Name Time Method The new Elisar Visual field analyser checks fixaitions accuratelyTimepoint: 4 weeks